{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:30:45Z","timestamp":1768440645522,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ejphar.2014.04.038","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T13:31:05Z","timestamp":1399383065000},"page":"63-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Novel mixed NOP\/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms"],"prefix":"10.1016","volume":"736","author":[{"given":"Marta","family":"Sobczak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerta","family":"Cami-Kobeci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Sa\u0142aga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Husbands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Fichna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.04.038_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.NAJ.0000431911.65473.35","article-title":"Managing irritable bowel syndrome","volume":"113","author":"Anastasi","year":"2013","journal-title":"Am. J. Nurs."},{"key":"10.1016\/j.ejphar.2014.04.038_bib2","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.2174\/138161212803582469","article-title":"Non-analgesic effects of opioids: opioid-induced respiratory depression","volume":"18","author":"Boom","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2014.04.038_bib3","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.1021\/jm2003238","article-title":"Structural determinants of opioid and NOP receptor activity in derivatives of buprenorphine","volume":"54","author":"Cami-Kobeci","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2014.04.038_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2004.11.052","article-title":"Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain","volume":"507","author":"Christoph","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.038_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1476-5381.1977.tb07533.x","article-title":"The animal pharmacology of buprenorphine, an oripavine analgesic agent","volume":"60","author":"Cowan","year":"1977","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.038_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1476-5381.1977.tb07532.x","article-title":"Agonist and antagonist properties of buprenorphine, a new antinociceptive agent","volume":"60","author":"Cowan","year":"1977","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.038_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/bja\/aep129","article-title":"Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile","volume":"103","author":"Dietis","year":"2009","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2014.04.038_bib8","first-page":"G749","article-title":"Increased visceral sensitivity to capsaicin after DSS-induced colitis in mice: spinal cord c-Fos expression and behavior","volume":"293","author":"Eijkelkamp","year":"2007","journal-title":"Am. J. Physiol.: Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2014.04.038_bib9","first-page":"16","article-title":"Common gastrointestinal symptoms: irritable bowel syndrome","volume":"413","author":"Fashner","year":"2013","journal-title":"FP Essent."},{"key":"10.1016\/j.ejphar.2014.04.038_bib10","doi-asserted-by":"crossref","first-page":"583-e212","DOI":"10.1111\/j.1365-2982.2011.01699.x","article-title":"Differential effects of salvinorin A on endotoxin-induced hypermotility and neurogenic ion transport in mouse ileum","volume":"23","author":"Fichna","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.ejphar.2014.04.038_bib11","doi-asserted-by":"crossref","first-page":"1326-e128","DOI":"10.1111\/j.1365-2982.2009.01369.x","article-title":"Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors","volume":"21","author":"Fichna","year":"2009","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.ejphar.2014.04.038_bib12","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1111\/nmo.12158","article-title":"The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice","volume":"25","author":"Fichna","year":"2013","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.ejphar.2014.04.038_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fphar.2012.00127","article-title":"Brain\u2013gut interactions in IBS","volume":"3","author":"Fichna","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.038_bib14","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.peptides.2010.04.018","article-title":"Synthesis and biological evaluation of novel peripherally active morphiceptin analogs","volume":"31","author":"Gach","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2014.04.038_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jpainsymman.2004.07.005","article-title":"Buprenorphine: considerations for pain management","volume":"29","author":"Johnson","year":"2005","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ejphar.2014.04.038_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/psc.2486","article-title":"Characterization of the effects of opiorphin and sialorphin and their analogs substituted in position 1 with pyroglutamic acid on motility in the mouse ileum","volume":"19","author":"Kamysz","year":"2013","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.ejphar.2014.04.038_bib17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1124\/jpet.109.156711","article-title":"Nociceptin\/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin\/orphanin FQ\/mu-opioid receptor agonists","volume":"331","author":"Khroyan","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.04.038_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0304-3959(01)00275-5","article-title":"A new model of visceral pain and referred hyperalgesia in the mouse","volume":"92","author":"Laird","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2014.04.038_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/10253891003664166","article-title":"Repeated psychological stress-induced alterations of visceral sensitivity and colonic motor functions in mice: influence of surgery and postoperative single housing on visceromotor responses","volume":"13","author":"Larauche","year":"2010","journal-title":"Stress"},{"key":"10.1016\/j.ejphar.2014.04.038_bib20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1021\/cn300124f","article-title":"The therapeutic potential of nociceptin\/orphanin FQ receptor agonists as analgesics without abuse liability","volume":"4","author":"Lin","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2014.04.038_bib21","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1523\/JNEUROSCI.23-32-10331.2003","article-title":"Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors","volume":"23","author":"Lutfy","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.04.038_bib22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1533-2500.2010.00378.x","article-title":"Current knowledge of buprenorphine and its unique pharmacological profile","volume":"10","author":"Pergolizzi","year":"2010","journal-title":"Pain Pract."},{"key":"10.1016\/j.ejphar.2014.04.038_bib23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.lfs.2009.02.025","article-title":"Bi- or multifunctional opioid peptide drugs","volume":"86","author":"Schiller","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2014.04.038_bib24","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2174\/13894501113149990174","article-title":"Nociceptin\/orphanin FQ (NOP) receptors as novel potential target in the treatment of gastrointestinal diseases","volume":"14","author":"Sobczak","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejphar.2014.04.038_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00535-013-0753-x","article-title":"Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives","volume":"49","author":"Sobczak","year":"2014","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2014.04.038_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.bjp.0707598","article-title":"Activities of mixed NOP and mu-opioid receptor ligands","volume":"153","author":"Spagnolo","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.038_bib27","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.109.157446","article-title":"Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor\/mu-opioid receptor ligands: implications for therapeutic applications","volume":"331","author":"Toll","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.04.038_bib28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.105.099937","article-title":"Thienorphine is a potent long-acting partial opioid agonist: a comparative study with buprenorphine","volume":"318","author":"Yu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.04.038_bib29","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3748\/wjg.v19.i9.1444","article-title":"Effect of thienorphine on intestinal transit and isolated guinea-pig ileum contraction","volume":"19","author":"Zhou","year":"2013","journal-title":"World J. Gastroenterol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914003343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914003343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T03:27:01Z","timestamp":1565407621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914003343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":29,"alternative-id":["S0014299914003343"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.04.038","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel mixed NOP\/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.04.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}